OFFICIAL PUBLICATION OF

by its subsidiary APPco

‘Atropt 1% should not be supplied.’

Megan Haggan 09/09/2019

Despite previously warning its pharmacist members about an error with atropine eye drops, PDL says it continues to receive incident reports about the problem In its latest practice alert for members, PDL has reminded pharmacists that “Atropine 0.01% eye drops are not commercially available and Atropt 1% should not be supplied”. “Despite warning its pharmacist

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘Consumer confusion, pharmacist frustration’ if current system continues

The first and foremost role of "expanded scope" is the HMR and collaborative medication management. A clear no brainer which…

Big Pharma

‘I can feel the walls closing in on me as this snowballs’

I'm yet to encounter a corporate provider, Debbie, with the benefits you describe around quality improvement with the corporate business…

Kelly Abbott

‘I can feel the walls closing in on me as this snowballs’

I would argue quality varies in any profession. Most GPs will not refer to a provider where the quality is…

Big Pharma

Wesfarmers targets affordable healthcare

When healthcare is treated as a commodity and patients regarded as consumers, health outcomes are compromised and overall healthcare spending…

Edward Hatfield

‘Atropt 1% should not be supplied.’

Previous Looking for irregularities

Next Drug testing an ‘upside-down’ policy

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous Looking for irregularities

Next Drug testing an ‘upside-down’ policy

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.